The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): A systematic literature review and meta-analysis

M Hamad Saied, L van der Griend… - Pediatric …, 2023 - Springer
Objective To review whether the current COVID-19 vaccines can prevent the occurrence of
multisystem inflammatory syndrome in children (MIS-C) and adolescents. Methods A …

[HTML][HTML] COVID-19 disease and autoimmune disorders: A mutual pathway

M Al-Beltagi, NK Saeed, AS Bediwy - World Journal of …, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is a real challenge for humanity with high
morbidity and mortality. Despite being primarily a respiratory illness, COVID-19 can affect …

The difference of the inflammatory milieu in MIS-C and severe COVID-19

SL Gurlevik, Y Ozsurekci, E Sağ, P Derin Oygar… - Pediatric …, 2022 - nature.com
Abstract Background Coronavirus disease 19 (COVID-19) may have a severe course in
children. Multisystem inflammatory syndrome in children (MIS-C) is the post-COVID …

Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19

Ş Çaǧlayan, HE Sönmez, G Otar Yener… - Frontiers in …, 2022 - frontiersin.org
Objective The study aimed to report the efficacy and safety of anakinra treatment in patients
with the refractory multisystemic inflammatory syndrome in children (MIS-C). Methods This is …

Multisystemic inflammatory syndrome in children, a disease with too many faces: a single-center experience

A Grama, SS Căinap, A Mititelu, C Blag, C Simu… - Journal of Clinical …, 2022 - mdpi.com
Background and aim: Multisystemic inflammatory syndrome in children (MIS-C) is a rare and
severe condition associated with Severe Acute Respiratory Syndrome Coronavirus (SARS …

Case report: Multisystem inflammatory syndrome in children associated with COVID-19, macrophage activation syndrome, and incomplete Kawasaki disease

JJ Martínez-García, JR López-Acosta… - Frontiers in …, 2023 - frontiersin.org
Background Multisystem inflammatory syndrome in children (MIS-C), is a severe
complication of coronavirus disease 2019 (COVID-19), characterized by persistent fever …

The trilogy of SARS-CoV-2 in pediatrics (Part 3): Thrombosis, anticoagulant, and antiplatelet considerations

VL Tran, S Parsons, CR Varela - The Journal of Pediatric …, 2021 - meridian.allenpress.com
The hypercoagulable state induced by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) affects all patients regardless of age. The incidence of venous …

Estudio de siete casos de Síndrome Inflamatorio Multisistémico Pediátrico Vinculado al SARS-CoV-2 y sus características en las diferentes olas de la pandemia

A Monllor Carrasquer - 2023 - riucv.ucv.es
El Síndrome Inflamatorio Multisistémico Pediátrico asociado al SARS-CoV-2 (SIM-PedS) es
una nueva entidad en Pediatría que se incluye en el diagnóstico diferencial del síndrome …

[PDF][PDF] Fardeau de la maladie dû au COVID-19 et effets négatifs de la lutte contre la pandémie chez les enfants (5-11 ans)(Version du 14.12. 2021)

ARN contre le COVID - infovac.ch
• Les cas de COVID-19 confirmés ont été de plus en plus nombreux chez les enfants et les
adolescents1 à mesure que la circulation du variant Delta du virus SARS-CoV-2 est …